The Falsified Medicines Directive is legislation passed by the European Union Parliament, which aims to increase the security of the manufacturing and delivery of medicines across Europe and protect patients and prevent falsified medicines from entering the supply chain.
The Government has released a Statutory Instruments (SI) The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 No. 775 outlining the changes to be made to regulations around the use of medicines in the UK, in the event of a No-Deal EU Exit.
A rare disease is officially classified as a condition that affects less than 5 in 10,000 in the general population, but smaller numbers of patients should not mean less focus on treating them.
NHS England has announced it has secured an agreement with Vertex to make available all three of their UK-licensed cystic fibrosis medicines.
Antimicrobial resistance is a global public health issue requiring multiple solutions and a sustained, coordinated response. The pharmaceutical industry is committed to tackling AMR working alongside governments and NGOs.
Outgoing Chief Medical Officer Professor Dame Sally Davies has been named as UK Special Envoy on antimicrobial resistance (AMR), working across all sectors including includes health, agriculture and the environment to tackle the global health threat.
New guidance to help the NHS and the pharmaceutical industry work successfully together.
The UK Life Sciences Industrial Strategy should be required reading for every healthcare leader in the UK. It makes clear that the NHS must be an active participant with industry in delivering the shared objective of outstanding patient outcomes.
Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history. Every year, 2 – 3 million lives are saved across the world because of immunisation.
Only clean water rivals vaccines at reducing infectious diseases and deaths1. Immunisation has the potential to prevent 6 million deaths worldwide each year2.